However, studies have shown that treatment with IFN-β or TGF-β blockade can polarize neutrophils to an “N1” antitumor phenotype, characterized by enhanced tumor cell phagocytosis and recruitment of T cells via CXCL10 [151, 152]. Here, IFNB1 is linked to neoplasm.